CORRECTED-Bayer keeps benefiting from euro weakness – report

BERLIN, July 11 (Reuters) - German pharmaceuticals group Bayer keeps benefiting from the weak euro, though the region's deepening debt crisis is beginning to weigh on orders in some sectors, a Swiss n…
Read the full story: Reuters: Healthcare